OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
NCT Number: NCT03135782
This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Portland, Oregon, 97239, United States
PRIMARY OBJECTIVES:
I. To determine if training providers on tobacco cessation resources increases the frequency of counseling and referrals at initial and follow-up consultations for cancer patients who use tobacco and are scheduled to receive radiation at Oregon Health and Science University (OHSU).
SECONDARY OBJECTIVES:
I. Increase provider frequency of tobacco use quantification and type. II. Increase frequency of provider assessment of tobacco cessation readiness in current users.
III. Increase frequency and types of tobacco cessation resources and medicines offered and utilized.
IV. Increase frequency and type of follow-up planned if referred to cessation resource.
OUTLINE:
MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training.
PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions.
PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo motivational interviewing training
Undergo medical chart review
Other names: Chart Review
Ancillary studies
Attend phone or in-person motivational interviewing coaching sessions
Time frame: Baseline up to 24 months
Will be compared between the cohort of pre and post intervention. Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Time frame: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Time frame: Baseline up to 24 months
Will be tested using a chi-squared test. If any expected cell count in the contingency table is lower than 5, we will instead use Fisher's exact test.
Time frame: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Time frame: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type. Will be tested using Z tests of proportion.
OHSU Knight Cancer Institute
Other
Integrating Tobacco Cessation Coaching Sessions Into Radiation Medicine Treatment: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT02465060
Adenocarcinoma, Adnexal Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07118176
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT04081779
Breast Carcinoma, Breast Diseases
Seattle, Washington, United States
View Trial Details